PROGRAM OVERVIEW
What You Can Expect from the Fall Clinical Lipid Update Program
From the latest treatment strategies for specialized populations to new analyses regarding the impact of different diets on cardiovascular and ASCVD risk, the NLA’s Fall Clinical Update presentations will provide you with need-to-know insights and clinical relevancies that will allow you to translate the science into practical patient care applications.
Our lineup of carefully selected presenters will:
- Explore different strategies of treatment in the diagnosis and management of specialized populations;
- Provide a framework for the integration of strategies to evaluate optimal lipid-lowering therapies;-
- Increase your effectiveness in managing effective diet and lifestyle strategies to reduce your patients’ risk for cardiovascular disease.
Join us in the Land of 10,000 Lakes in Minneapolis, Minnesota September 13-15 to expand your clinical lipidology expertise.
Edit Parent - PROGRAM (visibility Show)
AGENDA
| Friday, September 13 | |||
|---|---|---|---|
| 3:45 - 3:55 PM | Chapter Presidents Welcome & Introduction | ||
| Session I: NLA Scientific Statement Session | |||
| 4:00 - 4:05 PM | Pre-Session Audience Polling | ||
| 4:05 - 4:35PM | Lipid Laboratory Testing - NLA Scientific Statement | Seth S. Martin, MD, MHS | |
| 4:35 - 5:05 PM | Lp(a) Position Statement Paper - NLA Scientific Statement | Terry A. Jacobson, MD, FNLA | |
| 5:05 - 5:35 PM | NLA Positions on Lipid Laboratory Testing and Measurements: Addressing the Cases |
Eugenia Gianos, MD, |
|
| 5:35 - 5:40 PM | Post-Session Audience Polling | ||
| 5:40 - 6:00 PM | Question & Answer Panel | ||
| 6:00 - 7:00 PM | Welcome Reception in Exhibit Hall | ||
| 7:00 - 9:00 PM | CME/ CE Symposium: The Evolving Landscape of Triglyceride Lowering and Cardiovascular Outcomes: Clinical Pearls and Patient Application | ||
| Saturday, September 14 | |||
| 7:00 - 7:50 AM | Breakfast in Exhibit Hall | ||
| 7:50 - 8:00 AM | Housekeeping Notes | ||
| Session II: Risk Enhancers for Women | |||
| 8:00 - 8:05 AM | Pre-Session Audience Polling | ||
| 8:05 - 8:30 AM | Risk Enhancers for Women - Progress and Evolving Knowledge - The 2018 AHA/ACC Guidelines and Beyond | Ann Liebeskind, MD, FNLA | |
| 8:30 - 8:55 AM | Fatty Liver - Does Gender have an Impact? | Maya Balakrishnan, MD, MPH | |
| 8:55 - 9:20 AM | Obstetrical History and Cardiovascular Risk- What You Need to Know When Treating Your Lipid Patient | Laxmi Mehta, MD | |
| 9:20 - 9:40 AM | Question and Answer Panel | ||
| 9:40 - 10:20 AM | Break in Exhibit Hall | ||
| Session III: Low Carbohydrate Diets: is it Possible to Fuel up without Filling up? | |||
| 10:20 - 10:25 AM | Pre-Session Audience Polling | ||
| 10:25 - 10:50 AM | The Carbohydrate-Insulin Model of Obesity: Beyond 'Calories In, Calories Out' | David S. Ludwig, MD, PhD | |
| 10:50 - 11:15 AM | Dietary Patterns to Improve Clinical Outcomes for Type 2 Diabetes | Jackie Boucher, MS, RD, LD, CDE | |
| 11:15 - 11:40 AM | Low-Carbohydrate and Very-Low-Carbohydrate (including Ketogenic) Diets - NLA Scientific Statement | Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA | |
| 11:40 - 12:00 PM | Question and Answer Panel | ||
| 12:00 - 12:15 PM | MWLA and NELA Chapter News and Notes | ||
| 12:15 - 1:15 PM | Lunch in Exhibit Hall | ||
| 12:15 - 1:15 PM | Expert Theater Presentations | ||
| Session IV: Exercise is Medicine | |||
| 1:15 - 1:20 PM | Pre-Session Audience Polling | ||
| 1:20 - 1:45 PM | Fat, Exercise, and Cholesterol | Christopher Lundstrom, PhD | |
| 1:45 - 2:10 PM | Exercise is Medicine | Casey Elkins, DNP, MEd, NP-C, CLS, FNLA | |
| 2:10 - 2:35 PM | Increasing Physical Activity in Special Populations | Donald Dengel, PhD | |
| 2:35 - 2:55 PM | Question and Answer Panel | ||
| Session V: Tales from the Front: Case-Based Approaches to Implementing Optimal Lipid-Lowering Therapy | |||
| 2:55 - 3:00 PM | Pre-Session Audience Polling | ||
| 3:00 - 3:25 PM | What the 2018 Guidelines Recommend and Why | Lynne T. Braun, PhD, CNP, CLS | |
| 3:25 - 3:50 PM | Maximizing Patient-Clinician Discussions through Shared Decision Making | Guy L. Mintz, MD, FNLA | |
| 3:50 - 4:15 PM | Population Health Models to Improve Cholesterol Management | Michael S. Kelly, PharmD, CLS, FNLA | |
| 4:15 - 4:30 PM | Question and Answer Panel | ||
| 4:30 - 4:40 PM | Break | ||
| Session VI: Guess the Diagnosis: Uncommon Cases Presenting Commonly | |||
| 4:40 - 4:50 PM | Patient Case Presentation #1 Audience Voting – “Guess the Diagnosis” | James A. Underberg, MS, MD, FNLA | |
| 4:50 - 5:05 PM | Severe Hypercholesterolemia; What to do When Statins are not Enough | ||
| 5:05 - 5:15 PM | Patient Case Presentation #2 Audience Voting – “Guess the Diagnosis” | Premchand Anne, MD, MBA, MPH | |
| 5:15 - 5:30 PM | Did Statins Cause my Patient's Liver Damage? | ||
| 5:30 - 5:40 PM | Panel - Audience Discussion | ||
| 5:50 - 6:20 PM | Women in Lipidology 2019 Wind Down Meet Up | ||
| 7:30 - 8:30 PM | New Member Trivia | ||
| Sunday, September 15 | |||
| 7:00 - 7:50 AM | Breakfast | ||
| 7:50 - 8:00 AM | Housekeeping Notes | ||
| Session VII: Imaging in Cardiovascular Disease Prevention and Diagnosis | |||
| 8:00 - 8:05 AM | Pre-Session Audience Polling | ||
| 8:05 - 8:30 AM | Use of Coronary Calcium Scoring as it Pertains to the 2018 Guidelines | Matthew J. Budoff, MD | |
| 8:30 - 8:55 AM | Use of Coronary CTA and FFRct | Jamaluddin Moloo, MD, MPH | |
| 8:55 - 9:20 AM | Carotid IMT for Cardiovascular Risk Prediction - Does it Still Have a Role? | James Stein, MD, FNLA | |
| 9:20 - 9:45 AM | Epicardial Fat – Role in Metabolic Syndrome | Damini Dey, PhD | |
| 9:45 - 9:50 AM | Post-Session Audience Polling | ||
| 9:50 - 10:10 AM | Question & Answer Panel | ||
| Session VIII :Practical Approaches to the High-Risk Patient with PAD | |||
| 10:10 - 10:15 AM | Pre-Session Audience Polling | ||
| 10:15 - 10:40 AM | Lipid Management in Peripheral Arterial Disease- Let’s Step Up! | Jane Pearson, MD | |
| 10:40 - 11:05 AM | Medical Management of PAD: State of the Art in 2019 | Geoffrey Barnes, MD, MSc | |
| 11:05 - 11:30 AM | Considerations in Diabetes Management in High-risk Patients with PAD | Vijay Nambi, MD, PhD | |
| 11:30 - 11:35 AM | Post-Session Audience Polling | ||
| 11:35 - 11:55 AM | Question & Answer Panel | ||
| 11:55 AM | Adjourn | ||
ACCREDITATION
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.50 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 13.50 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 13.50 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.
Pharmacist Accreditation Statement
Universal Activity Number JA0007192-0000-19-022-L01-P (Application)
This Activity has been approved for 13.50 contact hour(s) (1.35 CEUs) of the Accreditation Council for Pharmacy Education
Nursing
The maximum number of hours awarded for this CE activity is 13.5 contact hours.
Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.
Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses, and registered dietitians with an interest in lipid management.
Type of Activity
Live Activity
Application
Educational Objectives
At the conclusion of this activity, all participants should be able to:
- Discuss strategies to improve the knowledge, skills or performance of the healthcare team;
Session I: NLA Scientific Statement Session
- Identify appropriate lipid laboratory testing in adults at risk for ASCVD.
- Recognize the clinical recommendations for measuring Lipoprotein(a) (Lp(a)) to manage ASCVD risk.
- Discuss the use of lipid testing for the management of dyslipidemia and ASCVD risk.
Session II: Risk Enhancers for Women
- Recognize gender differences in risk that impact clinical care to reduce cardiovascular disease.
- Review the evidence relating to the prevalence of non-alcoholic fatty liver disease (NAFLD) in postmenopausal women.
- Review strategies for managing CVD risk in women based on obstetrical history.
Session III: Low Carbohydrate Diets: is it Possible to Fuel up without Filling up?
- Describe evidence supporting a high fat/low carbohydrate diet on prevention and management of obesity-related chronic diseases.
- Explore the dietary evidence related to the management of type 2 diabetes.
- Recognize the impact of various dietary patterns on cardiometabolic and ASCVD risk.
Session IV: Exercise is Medicine
- Review the role of various types of physical activity on lipid management.
- Recognize the exercise stages of change in the management of patients with dyslipidemia.
- Discuss the appropriate use of physical activity in special populations.
Session V: Tales from the Front: Case-Based Approaches to Implementing Optimal Lipid-Lowering Therapy
- Review the rationale for the current cholesterol guidelines and the impact on treatment.
- Review evidence supporting multidisciplinary implementation strategies.
- Implement strategies that improve patient adherence and compliance to lipid-modifying therapies.
- Analyze the process of shared decision making related to the treatment of hypercholesterolemia.
- Interpret evidence evaluating the benefits of shared decision making when implementing lipid-lowering therapy.
- Discuss prevention and treatment strategies impacting the population at large.
- Review evidence evaluating multifaceted strategies to improve guideline implementation.
Session VI: Guess the Diagnosis: Uncommon Cases Presenting Commonly
- Demonstrate knowledge of the mechanisms and manifestations of complex lipid disorders.
- Counsel patients with complex lipid disorders on treatment and/or management plans.
Session VII: Imaging in Cardiovascular Disease Prevention and Diagnosis
- Discuss the clinical recommendations for the use of coronary calcium scoring.
- Recognize the diagnostic utility of coronary computed tomography angiography (CCTA) and fractional flow reserve (FFR).
- Identify the potential role of carotid IMT in cardiovascular risk assessment.
- Discuss the potential role of pericardial fat measurement on the increased risk of ASCVD.
Session VIII: Practical Approaches to the High-Risk Patient with PAD
- Discuss the evidence for benefits of statin therapy, ezetimibe, PCSK9i, and EPA in high-risk patients with PAD.
- Discuss role of aspirin, P2Y12 inhibitors, and anticoagulants in high-risk PAD.
- Describe the principles of lipid management for peripheral artery disease (PAD) prevention in patients with diabetes.
Ancillary Courses
Are you new to Lipidology or just looking to brush up on the changing information coming out in the field? Attend one of our ancillary courses taught by Experts in the area of Lipidology:
The NLA's Masters in Lipidology course provides an advanced examination of the core curriculum in Clinical Lipidology. This course is designed for any health care professional with experience in Lipidology who desires advanced training. Experts in the field of Lipidology will lecture on advanced concepts and guide participants through interactive learning scenarios that provide tools and skills to further advance personal standards of practice. It is recommended that attendees have already completed preparatory coursework (eg Foundations of Lipidology [formerly Lipid Academy] or similar core curriculum training).
The NLA's Foundations of Lipidology course, formerly Lipid Academy, provides an introductory review of the core curriculum in Clinical Lipidology. This course is designed for any healthcare professional seeking to learn the fundamentals of Lipidology. Experts in Lipidology will lecture on basic concepts and guide participants through interactive learning scenarios that provide the knowledge and tools necessary to work effectively in a lipid practice, and prepare for advanced training.
Delete PROGRAM
Edit Parent - VENUE (visibility Show)
Venue Information
Renaissance Minneapolis Hotel, The Depot
225 3rd Avenue South
Minneapolis, MN 55401
Meeting Room Rate: $179/night plus tax
Delete VENUE
Edit Parent - ENGAGE (visibility Show)
Social Media
Be part of the conversation and get the latest news and announcements from the Fall CLU. Follow the NLA on Twitter, Instagram, LinkedIn, and Facebook. Use the hashtag #NLAMinneapolis when posting about the meeting.
Delete ENGAGE
Edit Parent - SUPPORT (visibility Show)
Exhibit in Minneapolis
It is our pleasure to invite you to join us as an exhibitor at our 2019 Clinical Lipid Updates. NLA meetings provide you with an opportunity to reach your target audience of Lipidologists, Cardiologists, Endocrinologists, Primary Care Physicians, PhD researchers, and clinical team affiliates from an array of disciplines including nurses, nurse practitioners, physician assistants, pharmacists, exercise physiologists, and dietitians, in a uniquely intimate educational setting. We are proud to showcase not only an agenda led by distinguished faculty who are leaders in their fields, but a lively exhibit hall to act as a home base for our attendees. On behalf of our board of directors and the members we serve, we look forward to seeing you in Minneapolis.
Host a Symposium
The NLA has established that independently developed CME/CE-certified satellite symposia held in conjunction with the scientific meetings of the NLA are valuable opportunities to provide continuing education for our members and meeting participants.
In this regard, we are pleased to offer satellite symposia opportunities in conjunction with our 2019 Fall Clinical Lipid Update. Satellite symposia curriculum should include educational topics that complement or supplement the Fall CLU program agenda, addressing educational gaps preventing optimal patient care. Download our guidelines to view important information regarding hosting a satellite symposium, including the proposal creation and application processes.
Please contact the NLA Program Development department directly should you have any questions or require additional information. We hope to see you in Minneapolis!
Download Symposium Guidelines and Application:
Interested in non-CME programming? Please email exhibits@lipid.org
Delete SUPPORT
Edit Parent - SPECIAL EVENTS (visibility Show)
Symposia
Thursday, September 12 • 6:30 - 8:00pm
What is New in LDL-Apheresis Indications/Treatments
Kaneka Medical Products is proud to present a special educational dinner during the National Lipid Association - Clinical Lipid Update. This dynamic program will discuss what is new in LDL- Apheresis. Three experts will explore the topics of New FDA Indication for Lowering LDL-C, Acute Coronary Syndrome: Results of the Premiere Study, Treatment Options for Hyperlipidemia. The symposium will conclude with the panel of experts and audience participation of case studies about the topics discussed.
Dinner provided by Kaneka.
Location: Southern Pacific
Speakers:
Patrick M. Moriarty MD, FACP, FACC
Associate Professor of Internal Medicine
Director of Clinical Pharmacology
Medical Director of Atherosclerosis and LDL-Apheresis Clinic at the University of Kansas Medical Center in Kansas City
Seth S. Martin, MD, MHS, FACC, FAHA, FASPC
Associate Professor of Medicine - Cardiology
Johns Hopkins University School of Medicine
Firm Faculty, Janeway Firm, Osler Medical Residency
Director, Advanced Lipid Disorders Program, Ciccarone Center for the Prevention of Cardiovascular Disease
Associate Faculty, Welch Center for Prevention, Epidemiology, and Clinical Research
Affiliate Faculty, Malone Center for Engineering in Healthcare
Ehrin J. Armstrong, MD, MSc, MAS, FACC, FSCAI, FSVM
Director, Interventional Cardiology
Director, Vascular Laboratory
Rocky Mountain Regional VA Medical Center
Professor of Medicine and Division of Cardiology
University of Colorado School of Medicine
Hosted by Kaneka Pharma America
This event is not part of the National Lipid Association Clinical Lipid Update, as planned by the NLA Scientific Meetings Committee, and is not being certified for CME/CE credit.
Friday, September 13 • 7:00 - 9:00pm
The Evolving Landscape of Triglyceride Lowering and Cardiovascular Outcomes: Clinical Pearls and Patient Application
This 2-hour accredited program will feature expert discussions on the differences between EPA, DHA, and supplements, and trends and findings from recent cardiovascular outcomes trials including REDUCE-IT, and a patient case "workshop" facilitated by interactive iPad technology.
Dinner provided
Location: General Session (Great Northern)
Faculty:
Kevin C. Maki, PhD, CLS, FNLA, FTOS, FACN
President and Chief Scientist
Midwest Biomedical Research/MB Clinical Research
Ann C. Skulas-Ray, PhD
Assistant Professor, Department of Nutritional Sciences
The University of Arizona
James A. Underberg, MD, MS, FNLA
Clinical Assistant Professor of Medicine
Director, Bellevue Hospital
Hosted by the National Lipid Association
This activity is supported by educational funding provided by Amarin Pharma Inc.
Expert Theaters
Saturday, September 14 • 12:15 - 1:15pm
Amgen: Cardiovascular Patient Cases
Location: Southern Pacific
Speaker:
James A. Underberg, MD
Hosted by Amgen
PRALUENT®️ (alirocumab): Introducing New Clinical Data
Delete SPECIAL EVENTS
SCIENTIFIC MEETINGS CO-CHAIRS
Christie M. Ballantyne, MD, FNLA
Committee Co-Chair
Professor of Medicine
Chief, Section of Cardiovascular Research
Director, Center for Cardiovascular Disease Prevention
Baylor College of Medicine
Houston, TX
Anne C. Goldberg, MD, FACP, FNLA
Committee Co-Chair
President, Foundation of the NLA
Professor of Medicine
Washington University School of Medicine
St. Louis, MO
PROGRAM PLANNERS
Casey Elkins, DNP, MEd, NP-C, CLS, FNLA
Program Planner
Treasurer, Southeast Lipid Association
Assistant Dean for Academic Affairs
Director, DNP Program
University of South Alabama
College of Nursing
Mobile, AL
Edward M. Goldenberg, MD, FNLA
Program Planner
President, Northeast Lipid Association
Director Preventive Cardiology
Christiana Care
Newark, DE
Peter H. Jones, MD, FNLA
Program Planner
Director, Division of Cardiology
Associate Professor of Medicine Co-director,
Lipid Metabolism and Atherosclerosis Clinic Center for
Cardiovascular Disease Prevention
Houston Methodist DeBakey Heart and Vascular Center
Baylor College of Medicine
Houston, TX
Carol Kirkpatrick, PhD, RDN, MPH, CLS, FNLA
Program Planner
Wellness Center Director
Clinical Assistant Professor
Idaho State University
Pocatello, ID
Ann M. Liebeskind, MD, FNLA
Program Planner
President, Midwest Chapter Lipid Association
Founder
Mobile Health Team Lipids Clinic
Neenah, WI
Pamela B. Morris, MD, FNLA
Program Planner
Director, Preventive Cardiology
Co-Director, Women’s Heart Care
Medical University of South Carolina
Charleston, SC
Alan T. Remaley, MD, PhD
Program Planner
Section Chief Lipoprotein Metabolism Laboratory
National Heart, Lung, and Blood Institute
National Institutes of Health
Bethesda, MD
Joseph J. Saseen, PharmD, CLS, FNLA
Program Planner
President-Elect, National Lipid Association
Professor and Vice Chair
Department of Clinical Pharmacy
Professor, Department of Family Medicine
University of Colorado
Anschutz Medical Campus
Aurora, CO
Daniel E. Soffer, MD, FNLA
Program Planner
University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Perelman Center for Advanced Medicine
Philadelphia, PA
FACULTY
Premchand Anne, MD, MPH, MBA
Director of Pediatric Cardiology
Ascension St. John Children's Hospital
Clinical Assistant Professor of Pediatrics
Wayne State University School of Medicine
Detroit, MI
Maya Balakrishnan, MD, MPH
Assistant Professor
Department of Medicine, Section of Gastroenterology
Baylor College of Medicine
Houston, TX
Geoffrey Barnes, MD, MSc
Assistant Professor of Internal Medicine
Vascular and Cardiovascular Medicine
University of Michigan Medical School
Ann Arbor, MI
Jackie Boucher, MS, RD
President
Children’s HeartLink
Minneapolis, MN
Lynne T. Braun, PhD, CNP, CLS, FNLA
Professor, Colleges of Nursing and Medicine
Rush University
Nurse Practitioner
Rush Heart Center for Women
Rush University Medical Center
Chicago, IL
Matthew J. Budoff, MD
Professor of Medicine
University of California, Los Angeles
Endowed Chair of Preventive Cardiology
Director, Cardiac CT
Los Angeles Biomedical Research Institute
Torrance, CA
Donald R. Dengel, PhD
Henry L. Taylor-Arthur S. Leon Professorship in Exercise
Science and Health Enhancement
Professor of Kinesiology
University of Minnesota
Minneapolis, MN
Damini Dey, PhD
Director, Quantitative Image Analysis Lab
Biomedical Imaging Research Institute
Technical Co-Director, PET/MR Services
Biomedical Imaging Research Institute
Associate Professor, Biomedical Sciences
Cedars-Sinai
Los Angeles, CA
Terry A. Jacobson, MD, FNLA
Professor of Medicine
Director, Office of Health Promotion and Disease Prevention
Emory University
Atlanta, GA
Michael S. Kelly, PharmD, CLS, FNLA
Assistant Professor of Pharmacy Practice
Chapman University School of Pharmacy
Irvine, CA
David S. Ludwig, MD, PhD
Physician, Boston Children’s Hospital
Professor, Pediatrics
Harvard Medical School
Boston, MA
Christopher J. Lundstrom, PhD
University of Minnesota
School of Kinesiology
Lecturer, Sport and Exercise Science
M.Ed. Director, Sport and Exercise Science; Physical Activity and Health
MHealth
Fitness Development Coach and Exercise Physiologist
Minneapolis, MN
Seth S. Martin, MD, MHS
Assistant Professor of Medicine
Division of Cardiology
Department of Medicine
Johns Hopkins University School of Medicine
Director, Advanced Lipid Disorders Program Ciccarone Center for
the Prevention of Cardiovascular Disease
Baltimore, MD
Laxmi Mehta, MD
Section Director of Preventative Cardiology &
Women’s Cardiovascular Health
Director of Lipid Clinics
Sarah Ross Soter Endowed Chair in
Women’s Cardiovascular Health
Professor of Medicine
The Ohio State University
Columbus, OH
Guy L. Mintz, MD, FNLA
Director of Cardiovascular Health & Lipidology
Sandra Atlas Bass Heart Hospital
North Shore University Hospital
Associate Professor of Medicine
Zucker School of Medicine
Manhasset, NY
Jamaluddin Moloo, MD, MPH
Associate Professor
Director, Cardiac CT
Cardiac and Vascular Center
Departments of Medicine and Radiology
University of Colorado
Aurora, CO
Vijay Nambi, MD, PhD
Staff Cardiologist Michael E DeBakey Veterans Affairs Hospital
Associate Professor
Medicine- Atherosclerosis and Lipoprotein
Baylor College of Medicine
Houston, TX
Jane K. Pearson, MD
Preventive Cardiology, Program Director
Cardiac Rehabilitation, Medical Director
SSM Health, Dean Medical Group
Madison, WI
James H. Stein, MD, FNLA
Robert Turell Professor in Cardiovascular Research
Director, Atherosclerosis Imaging Research Program
Director, Preventive Cardiology
Robert Turell Professor in Cardiovascular Research Department of Medicine
Cardiovascular Medicine Division
University of Wisconsin School of Medicine and Public Health
Madison, WI
James A. Underberg, MD, MS, FNLA
Past- President, National Lipid Association
Clinical Assistant Professor of Medicine
Director, Bellevue Hospital Lipid Clinic
New York, NY
Register for 2019 Fall Clinical Lipid Update
Disclaimer
Registration: Online registration and payment must be received no later than September 14, 2019. After this date, meeting materials and name badge cannot be guaranteed, but onsite registration will be available until September 15, 2019. By registering for this meeting, attendee understands and agrees that attendee’s name, city, and state may be shared with other attendees and exhibitors. By allowing an exhibitor to scan the conference badge, attendee understands, agrees and consents to the sharing of attendee’s contact information with the company that scanned the conference badge.
Photography: Photographs and/or video may be taken as part of the registered event. By registering for this event, you grant the National Lipid Association full rights to use the images resulting from the photography/video filming and any reproductions or adaptations of the images for promotional purposes. This may include (but is not limited to), the right to use them in print and online platforms, social media, press releases and other outlets.
Cancellation: Telephone cancellations will not be accepted. A written notice of cancellation must be received no later than August 13, 2019. This includes social events and guest fees. There will be a $100 fee for all cancellations. There will be no refunds if cancelling within 30 days of the start of the meeting date.
Attendees who need special reasonable accommodations or who have special needs should contact the meeting organizers at 904-998-0854.